Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Calais

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology GroupLaurence Collette, Jean-Francois Bosset, Marcel den Dulk, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systemsFabrice Denis, Pascal Garaud, Etienne Bardet, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II studyMelanie Fesneau, Yoann Pointreau, Sophie Chapet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2020
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trialGuillaume Janoray, Yoann Pointreau, Marc Alfonsi, et al.
American Journal of Clinical Oncology|June 7, 2007
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter studyJean-Luc Labourey, Didier Cupissol, Gilles Calais, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trialGilles Calais, Etienne Bardet, Christian Sire, et al.
Cancer|November 30, 2007
Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancerRene-Jean Bensadoun, Jamel Daoud, Brahim El Gueddari, et al.
The New England Journal of Medicine|September 15, 2006
Chemotherapy with preoperative radiotherapy in rectal cancerJean-François Bosset, Laurence Collette, Gilles Calais, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology GroupLaurence Collette, Jean-Francois Bosset, Marcel den Dulk, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systemsFabrice Denis, Pascal Garaud, Etienne Bardet, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II studyMelanie Fesneau, Yoann Pointreau, Sophie Chapet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2020
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trialGuillaume Janoray, Yoann Pointreau, Marc Alfonsi, et al.
American Journal of Clinical Oncology|June 7, 2007
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter studyJean-Luc Labourey, Didier Cupissol, Gilles Calais, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized studyAlain Toledano, Pascal Garaud, Daniel Serin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trialGilles Calais, Etienne Bardet, Christian Sire, et al.
Cancer|November 30, 2007
Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancerRene-Jean Bensadoun, Jamel Daoud, Brahim El Gueddari, et al.
The New England Journal of Medicine|September 15, 2006
Chemotherapy with preoperative radiotherapy in rectal cancerJean-François Bosset, Laurence Collette, Gilles Calais, et al.
Pageof 6